The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a loss of -50.24%.However, over the last six months, we can see a stronger performance of -53.58%. Over the last 30 days, the price of THRD has leaped by -54.16%. And in the last five days, it has fallen by -4.30%.
Third Harmonic Bio Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $16.94 on 05/21/24 and the lowest value was $4.62 on 02/05/25.
52-week price history of THRD Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Third Harmonic Bio Inc’s current trading price is -69.78% away from its 52-week high, while its distance from the 52-week low is 10.82%. The stock’s price range during this period has varied between$4.62 and $16.94. The Third Harmonic Bio Inc’s shares, which operate in the Healthcare, saw a trading volume of around 0.55 million for the day, a figure considerably higher than their average daily volume of 0.25 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Third Harmonic Bio Inc (THRD) has experienced a quarterly decline of -57.70% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 230.70M and boasts a workforce of 30 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 11.24, with a change in price of -8.13. Similarly, Third Harmonic Bio Inc recorded 251,364 in trading volume during the last 100 days, posting a change of -61.36%.
THRD’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for THRD stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.01.
THRD Stock Stochastic Average
Third Harmonic Bio Inc’s raw stochastic average for the past 50 days is presently 5.61%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 7.82%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 2.80% and 2.13%, respectively.
